{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T15:59:30Z","timestamp":1793721570896,"version":"4.6.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"UK Government Department of Health and Social Care."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Aging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We studied humoral and cellular immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 152 long-term care facility staff and 124 residents over a prospective 4-month period shortly after the first wave of infection in England. We show that residents of long-term care facilities developed high and stable levels of antibodies against spike protein and receptor-binding domain. Nucleocapsid-specific responses were also elevated but waned over time. Antibodies showed stable and equivalent levels of functional inhibition against spike-angiotensin-converting enzyme 2 binding in all age groups with comparable activity against viral variants of concern. SARS-CoV-2 seropositive donors showed high levels of antibodies to other beta-coronaviruses but serostatus did not impact humoral immunity to influenza or other respiratory syncytial viruses. SARS-CoV-2-specific cellular responses were similar across all ages but virus-specific populations showed elevated levels of activation in older donors. Thus, survivors of SARS-CoV-2 infection show a robust and stable immunity against the virus that does not negatively impact responses to other seasonal viruses.<\/jats:p>","DOI":"10.1038\/s43587-022-00224-w","type":"journal-article","created":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T12:03:50Z","timestamp":1653912230000},"page":"536-547","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Robust SARS-CoV-2-specific and heterologous immune responses in vaccine-na\u00efve residents of long-term care facilities who survive natural infection"],"prefix":"10.1038","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0655-232X","authenticated-orcid":false,"given":"Gokhan","family":"Tut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2872-4794","authenticated-orcid":false,"given":"Tara","family":"Lancaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan S.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiota","family":"Sylla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliska","family":"Spalkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayandeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Bentley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9933-8914","authenticated-orcid":false,"given":"Umayr","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azar T.","family":"Jadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Hulme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morenike","family":"Ayodel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1909-7047","authenticated-orcid":false,"given":"Alexander C.","family":"Dowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8380-8122","authenticated-orcid":false,"given":"Hayden","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Margielewska-Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kriti","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Nicol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jusnara","family":"Begum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Jinks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Tut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Bruton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Krutikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhumita","family":"Shrotri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Giddings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borscha","family":"Azmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidan","family":"Irwin-Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Copas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1713-2555","authenticated-orcid":false,"given":"Laura","family":"Shallcross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6895-1967","authenticated-orcid":false,"given":"Paul","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,30]]},"reference":[{"key":"224_CR1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jinf.2020.05.073","volume":"81","author":"NSN Graham","year":"2020","unstructured":"Graham, N. S. N. et al. SARS-CoV-2 infection, clinical features and outcome of COVID-19 in United Kingdom nursing homes. J. Infect. 81, 411\u2013419 (2020).","journal-title":"J. Infect."},{"key":"224_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/ageing\/afaa207","volume":"50","author":"J Hollinghurst","year":"2021","unstructured":"Hollinghurst, J. et al. The impact of COVID-19 on adjusted mortality risk in care homes for older adults in Wales, UK: a retrospective population-based cohort study for mortality in 2016\u20132020. Age Ageing 50, 25\u201331 (2021).","journal-title":"Age Ageing"},{"key":"224_CR3","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/ageing\/afab060","volume":"50","author":"PF Dutey-Magni","year":"2021","unstructured":"Dutey-Magni, P. F. et al. COVID-19 infection and attributable mortality in UK care homes: cohort study using active surveillance and electronic records (March\u2013June 2020). Age Ageing 50, 1019\u20131028 (2021).","journal-title":"Age Ageing"},{"key":"224_CR4","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1093\/gerona\/glaa183","volume":"75","author":"JL Atkins","year":"2020","unstructured":"Atkins, J. L. et al. Preexisting comorbidities predicting severe COVID-19 and mortality in the UK Biobank community cohort. J. Gerontol. A Biol. Sci. Med. Sci. 75, 2224\u20132230 (2020).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"224_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-01945-2","volume":"19","author":"M Morciano","year":"2021","unstructured":"Morciano, M., Stokes, J., Kontopantelis, E., Hall, I. & Turner, A. J. Excess mortality for care home residents during the first 23 weeks of the COVID-19 pandemic in England: a national cohort study. BMC Med. 19, 71 (2021).","journal-title":"BMC Med."},{"key":"224_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12979-021-00219-y","volume":"18","author":"G Pawelec","year":"2021","unstructured":"Pawelec, G. & McElhaney, J. Unanticipated efficacy of SARS-CoV-2 vaccination in older adults. Immun. Ageing 18, 7 (2021).","journal-title":"Immun. Ageing"},{"key":"224_CR7","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/S1473-3099(21)00289-9","volume":"21","author":"M Shrotri","year":"2021","unstructured":"Shrotri, M. et al. Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study. Lancet Infect. Dis. 21, 1529\u20131538 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"224_CR8","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nri1886","volume":"6","author":"A Radbruch","year":"2006","unstructured":"Radbruch, A. et al. Competence and competition: the challenge of becoming a long-lived plasma cell. Nat. Rev. Immunol. 6, 741\u2013750 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"224_CR9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","volume":"15","author":"L Ferrucci","year":"2018","unstructured":"Ferrucci, L. & Fabbri, E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat. Rev. Cardiol. 15, 505\u2013522 (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"224_CR10","doi-asserted-by":"publisher","unstructured":"Gallais, F. et al. Anti-SARS-CoV-2 antibodies persist for up to 13 months and reduce risk of reinfection. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2021.05.07.21256823 (2021).","DOI":"10.1101\/2021.05.07.21256823"},{"key":"224_CR11","doi-asserted-by":"publisher","first-page":"107725","DOI":"10.1016\/j.celrep.2020.107725","volume":"31","author":"H Lv","year":"2020","unstructured":"Lv, H. et al. Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections. Cell Rep. 31, 107725 (2020).","journal-title":"Cell Rep."},{"key":"224_CR12","doi-asserted-by":"publisher","unstructured":"Dowell, A.C., Butler, M.S., Jinks, E. et al. Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection. Nat. Immunol. 23, 40\u201349 (2022). https:\/\/doi.org\/10.1038\/s41590-021-01089-8","DOI":"10.1038\/s41590-021-01089-8"},{"key":"224_CR13","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1126\/science.abe1107","volume":"370","author":"KW Ng","year":"2020","unstructured":"Ng, K. W. et al. Preexisting and de novo humoral immunity to SARS-CoV-2 in humans. Science 370, 1339\u20131343 (2020).","journal-title":"Science"},{"key":"224_CR14","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41590-021-00902-8","volume":"22","author":"J Zuo","year":"2021","unstructured":"Zuo, J. et al. Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection. Nat. Immunol. 22, 620\u2013626 (2021).","journal-title":"Nat. Immunol."},{"key":"224_CR15","doi-asserted-by":"publisher","first-page":"2100092","DOI":"10.2807\/1560-7917.ES.2021.26.5.2100092","volume":"26","author":"A Jeffery-Smith","year":"2021","unstructured":"Jeffery-Smith, A. et al. Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020. Euro Surveill. 26, 2100092 (2021).","journal-title":"Euro Surveill."},{"key":"224_CR16","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1016\/S2666-7568(21)00093-3","volume":"2","author":"M Krutikov","year":"2021","unstructured":"Krutikov, M. et al. Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 long-term care facilities (VIVALDI): a prospective cohort study. Lancet Healthy Longev. 2, e362\u2013e370 (2021).","journal-title":"Lancet Healthy Longev."},{"key":"224_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18450-4","volume":"11","author":"AT Huang","year":"2020","unstructured":"Huang, A. T. et al. A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity. Nat. Commun. 11, 4704 (2020).","journal-title":"Nat. Commun."},{"key":"224_CR18","doi-asserted-by":"publisher","first-page":"eabe0367","DOI":"10.1126\/sciimmunol.abe0367","volume":"5","author":"AS Iyer","year":"2020","unstructured":"Iyer, A. S. et al. Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients. Sci. Immunol. 5, eabe0367 (2020).","journal-title":"Sci. Immunol."},{"key":"224_CR19","doi-asserted-by":"publisher","first-page":"e1003656","DOI":"10.1371\/journal.pmed.1003656","volume":"18","author":"F Tea","year":"2021","unstructured":"Tea, F. et al. SARS-CoV-2 neutralizing antibodies: longevity, breadth, and evasion by emerging viral variants. PLoS Med. 18, e1003656 (2021).","journal-title":"PLoS Med."},{"key":"224_CR20","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1007\/s42399-020-00619-z","volume":"2","author":"C Sonkar","year":"2020","unstructured":"Sonkar, C., Kashyap, D., Varshney, N., Baral, B. & Jha, H. C. Impact of gastrointestinal symptoms in COVID-19: a molecular approach. SN Compr. Clin. Med. 2, 2658\u20132669 (2020).","journal-title":"SN Compr. Clin. Med."},{"key":"224_CR21","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1016\/j.cell.2021.03.036","volume":"184","author":"M Hoffmann","year":"2021","unstructured":"Hoffmann, M. et al. SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies. Cell 184, 2384\u20132393.e12 (2021).","journal-title":"Cell"},{"key":"224_CR22","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1126\/science.aay6485","volume":"366","author":"MJ Mina","year":"2019","unstructured":"Mina, M. J. et al. Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens. Science 366, 599\u2013606 (2019).","journal-title":"Science"},{"key":"224_CR23","doi-asserted-by":"publisher","first-page":"eaay6125","DOI":"10.1126\/sciimmunol.aay6125","volume":"4","author":"VN Petrova","year":"2019","unstructured":"Petrova, V. N. et al. Incomplete genetic reconstitution of B cell pools contributes to prolonged immunosuppression after measles. Sci. Immunol. 4, eaay6125 (2019).","journal-title":"Sci. Immunol."},{"key":"224_CR24","doi-asserted-by":"publisher","first-page":"100354","DOI":"10.1016\/j.xcrm.2021.100354","volume":"2","author":"KW Cohen","year":"2021","unstructured":"Cohen, K. W. et al. Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells. Cell Rep. Med. 2, 100354 (2021).","journal-title":"Cell Rep. Med."},{"key":"224_CR25","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","volume":"584","author":"N Le Bert","year":"2020","unstructured":"Le Bert, N. et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature 584, 457\u2013462 (2020).","journal-title":"Nature"},{"key":"224_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-83991-7","volume":"11","author":"A Alberro","year":"2021","unstructured":"Alberro, A. et al. Inflammaging markers characteristic of advanced age show similar levels with frailty and dependency. Sci. Rep. 11, 4358 (2021).","journal-title":"Sci. Rep."},{"key":"224_CR27","doi-asserted-by":"publisher","first-page":"e544","DOI":"10.1016\/S2666-7568(21)00168-9","volume":"2","author":"G Tut","year":"2021","unstructured":"Tut, G. et al. Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study. Lancet Healthy Longev. 2, e544\u2013e553 (2021).","journal-title":"Lancet Healthy Longev."},{"key":"224_CR28","doi-asserted-by":"publisher","first-page":"232","DOI":"10.12688\/wellcomeopenres.16193.1","volume":"5","author":"M Krutikov","year":"2020","unstructured":"Krutikov, M. et al. Study protocol: understanding SARS-Cov-2 infection, immunity and its duration in care home residents and staff in England (VIVALDI). Wellcome Open Res. 5, 232 (2020).","journal-title":"Wellcome Open Res."},{"key":"224_CR29","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/S1473-3099(20)30634-4","volume":"20","author":"M Ainsworth","year":"2020","unstructured":"Ainsworth, M. et al. Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison. Lancet Infect. Dis. 20, 1390\u20131400 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"224_CR30","doi-asserted-by":"publisher","first-page":"e00941-","DOI":"10.1128\/JCM.00941-20","volume":"58","author":"A Bryan","year":"2020","unstructured":"Bryan, A. et al. Performance characteristics of the Abbott ARCHITECT SARS-CoV-2 IgG assay and seroprevalence in Boise, Idaho. J. Clin. Microbiol. 58, e00941-20 (2020).","journal-title":"J. Clin. Microbiol."}],"container-title":["Nature Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43587-022-00224-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-022-00224-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-022-00224-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T05:20:32Z","timestamp":1669353632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43587-022-00224-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,30]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["224"],"URL":"https:\/\/doi.org\/10.1038\/s43587-022-00224-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.08.13.21261889","asserted-by":"object"}]},"ISSN":["2662-8465"],"issn-type":[{"value":"2662-8465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,30]]},"assertion":[{"value":"19 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.S. reports grants from the Department of Health and Social Care during the conduct of the study and is a member of the Social Care Working Group, which reports to the Scientific Advisory Group for Emergencies. A.H. is a member of the New and Emerging Respiratory Virus Threats Advisory Group at the Department of Health. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}